175 related articles for article (PubMed ID: 30506735)
1. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia major.
Li XY; Huang K; Zhou DH; Li Y; Xu HG; Weng WJ; Xu LH; Fang JP
Clin Transplant; 2019 Jan; 33(1):e13459. PubMed ID: 30506735
[TBL] [Abstract][Full Text] [Related]
2. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.
Gaziev J; Marziali S; Paciaroni K; Isgrò A; Di Giuliano F; Rossi G; Marziali M; De Angelis G; Alfieri C; Ribersani M; Andreani M; Palmieri MG; Placidi F; Romigi A; Izzi F; Floris R; Mercuri NB
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1531-1540. PubMed ID: 28602890
[TBL] [Abstract][Full Text] [Related]
3. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation with Beta Major Thalassemia: The Association between the PRES Occurrence and Class of Beta Major Thalassemia.
Jafari L; Behfar M; Tabatabaie S; Karamlou Y; Kashani H; Radmard AR; Mohseni R; Naji P; Ghanbari F; Ashkevari P; Fakhr H; Mohammadi S; Hamidieh AA
Clin Transplant; 2024 Jan; 38(1):e15164. PubMed ID: 37847603
[TBL] [Abstract][Full Text] [Related]
4. Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents.
Dandoy CE; Linscott LL; Davies SM; Leach JL; Myers KC; El-Bietar J; Chima RS; Pate A; Nelson A; Wallace G; Wong HR; Jodele S
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2028-32. PubMed ID: 26226408
[TBL] [Abstract][Full Text] [Related]
5. Posterior Reversible Encephalopathy Syndrome in Children:: A Prospective Follow-up Study.
Darwish AH
J Child Neurol; 2020 Jan; 35(1):55-62. PubMed ID: 31570037
[TBL] [Abstract][Full Text] [Related]
6. Posterior reversible encephalopathy syndrome after pediatric heart transplantation: Increased risk for children with preexisting Glenn/Fontan physiology.
Eilers B; Albers E; Law Y; McMullan DM; Shaw D; Kemna M
Pediatr Transplant; 2016 Jun; 20(4):552-8. PubMed ID: 27139146
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients.
Atça AÖ; Erok B; Aydoğdu S
BMC Pediatr; 2021 Oct; 21(1):445. PubMed ID: 34629063
[TBL] [Abstract][Full Text] [Related]
8. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes.
Chen Q; Zhao X; Fu HX; Chen YH; Zhang YY; Wang JZ; Wang Y; Wang FR; Mo XD; Han W; Chen H; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
Bone Marrow Transplant; 2020 Oct; 55(10):2035-2042. PubMed ID: 32305999
[TBL] [Abstract][Full Text] [Related]
10. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome.
Fukuyama T; Tanaka M; Nakazawa Y; Motoki N; Inaba Y; Higuchi T; Koike K
Pediatr Transplant; 2011 Dec; 15(8):E169-73. PubMed ID: 20735807
[TBL] [Abstract][Full Text] [Related]
12. Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation.
Cordelli DM; Masetti R; Bernardi B; Barcia G; Gentile V; Biagi C; Prete A; Pession A; Franzoni E
Pediatr Blood Cancer; 2012 May; 58(5):785-90. PubMed ID: 21990274
[TBL] [Abstract][Full Text] [Related]
13. Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.
Chen S; Hu J; Xu L; Brandon D; Yu J; Zhang J
Mol Neurobiol; 2016 Dec; 53(10):6897-6909. PubMed ID: 26666662
[TBL] [Abstract][Full Text] [Related]
14. Peak blood pressure and prediction of posterior reversible encephalopathy syndrome in children.
Gall E; Chaudhuri A; South AM
Pediatr Nephrol; 2020 Oct; 35(10):1967-1975. PubMed ID: 32385528
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation.
Hammerstrom AE; Howell J; Gulbis A; Rondon G; Champlin RE; Popat U
Am J Hematol; 2013 Apr; 88(4):301-5. PubMed ID: 23460378
[TBL] [Abstract][Full Text] [Related]
16. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome.
Ishikura K; Ikeda M; Hamasaki Y; Hataya H; Nishimura G; Hiramoto R; Honda M
Nephrol Dial Transplant; 2008 Aug; 23(8):2531-6. PubMed ID: 18258739
[TBL] [Abstract][Full Text] [Related]
17. Childhood posterior reversible encephalopathy syndrome: Magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal.
Agarwal A; Kapur G; Altinok D
Neuroradiol J; 2015 Dec; 28(6):638-43. PubMed ID: 26515749
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitor-free strategies for prophylaxis and treatment of GVHD in children with posterior reversible encephalopathy syndrome after stem cell transplantation.
Shkalim-Zemer V; Konen O; Levinsky Y; Michaeli O; Yahel A; Krauss A; Yaniv I; Stein J
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417553
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease.
Bhunia N; Abu-Arja R; Bajwa RPS; Auletta JJ; Rangarajan HG
Pediatr Blood Cancer; 2019 Oct; 66(10):e27912. PubMed ID: 31264793
[TBL] [Abstract][Full Text] [Related]
20. Posterior Reversible Encephalopathy Syndrome after Allogeneic Stem Cell Transplantation in Pediatric Patients with Fanconi Anemia, a Prospective Study.
Behfar M; Babaei M; Radmard AR; Kooraki S; Farajifard H; Naji P; Taebi S; Hamidieh AA
Biol Blood Marrow Transplant; 2020 Dec; 26(12):e316-e321. PubMed ID: 32860910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
